Literature DB >> 18339846

Prediction of cancer driver mutations in protein kinases.

Ali Torkamani1, Nicholas J Schork.   

Abstract

A large number of somatic mutations accumulate during the process of tumorigenesis. A subset of these mutations contribute to tumor progression (known as "driver" mutations) whereas the majority of these mutations are effectively neutral (known as "passenger" mutations). The ability to differentiate between drivers and passengers will be critical to the success of upcoming large-scale cancer DNA resequencing projects. Here we show a method capable of discriminating between drivers and passengers in the most frequently cancer-associated protein family, protein kinases. We apply this method to multiple cancer data sets, validating its accuracy by showing that it is capable of identifying known drivers, has excellent agreement with previous statistical estimates of the frequency of drivers, and provides strong evidence that predicted drivers are under positive selection by various sequence and structural analyses. Furthermore, we identify particular positions in protein kinases that seem to play a role in oncogenesis. Finally, we provide a ranked list of candidate driver mutations.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18339846     DOI: 10.1158/0008-5472.CAN-07-5283

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  56 in total

Review 1.  Annotating individual human genomes.

Authors:  Ali Torkamani; Ashley A Scott-Van Zeeland; Eric J Topol; Nicholas J Schork
Journal:  Genomics       Date:  2011-08-02       Impact factor: 5.736

2.  PertInInt: An Integrative, Analytical Approach to Rapidly Uncover Cancer Driver Genes with Perturbed Interactions and Functionalities.

Authors:  Shilpa Nadimpalli Kobren; Bernard Chazelle; Mona Singh
Journal:  Cell Syst       Date:  2020-07-14       Impact factor: 10.304

3.  The chaperones Hsp90 and Cdc37 mediate the maturation and stabilization of protein kinase C through a conserved PXXP motif in the C-terminal tail.

Authors:  Christine M Gould; Natarajan Kannan; Susan S Taylor; Alexandra C Newton
Journal:  J Biol Chem       Date:  2008-12-17       Impact factor: 5.157

4.  Computational modeling of structurally conserved cancer mutations in the RET and MET kinases: the impact on protein structure, dynamics, and stability.

Authors:  Anshuman Dixit; Ali Torkamani; Nicholas J Schork; Gennady Verkhivker
Journal:  Biophys J       Date:  2009-02       Impact factor: 4.033

5.  Congenital disease SNPs target lineage specific structural elements in protein kinases.

Authors:  Ali Torkamani; Natarajan Kannan; Susan S Taylor; Nicholas J Schork
Journal:  Proc Natl Acad Sci U S A       Date:  2008-06-25       Impact factor: 11.205

6.  The (un)targeted cancer kinome.

Authors:  Oleg Fedorov; Susanne Müller; Stefan Knapp
Journal:  Nat Chem Biol       Date:  2010-03       Impact factor: 15.040

Review 7.  Kinase mutations in human disease: interpreting genotype-phenotype relationships.

Authors:  Piya Lahiry; Ali Torkamani; Nicholas J Schork; Robert A Hegele
Journal:  Nat Rev Genet       Date:  2010-01       Impact factor: 53.242

8.  In silico functional profiling of human disease-associated and polymorphic amino acid substitutions.

Authors:  Matthew Mort; Uday S Evani; Vidhya G Krishnan; Kishore K Kamati; Peter H Baenziger; Angshuman Bagchi; Brandon J Peters; Rakesh Sathyesh; Biao Li; Yanan Sun; Bin Xue; Nigam H Shah; Maricel G Kann; David N Cooper; Predrag Radivojac; Sean D Mooney
Journal:  Hum Mutat       Date:  2010-03       Impact factor: 4.878

9.  A Bayesian ensemble approach with a disease gene network predicts damaging effects of missense variants of human cancers.

Authors:  Hong-Hee Won; Jong-Won Kim; Doheon Lee
Journal:  Hum Genet       Date:  2012-08-21       Impact factor: 4.132

10.  Identifying critical non-catalytic residues that modulate protein kinase A activity.

Authors:  Eileen J Kennedy; Jie Yang; Lorraine Pillus; Susan S Taylor; Gourisankar Ghosh
Journal:  PLoS One       Date:  2009-03-09       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.